Literature DB >> 26628741

Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry.

Etienne Caron1, Daniel J Kowalewski2, Ching Chiek Koh3, Theo Sturm3, Heiko Schuster2, Ruedi Aebersold4.   

Abstract

The myriad of peptides presented at the cell surface by class I and class II major histocompatibility complex (MHC) molecules are referred to as the immunopeptidome and are of great importance for basic and translational science. For basic science, the immunopeptidome is a critical component for understanding the immune system; for translational science, exact knowledge of the immunopeptidome can directly fuel and guide the development of next-generation vaccines and immunotherapies against autoimmunity, infectious diseases, and cancers. In this mini-review, we summarize established isolation techniques as well as emerging mass spectrometry-based platforms (i.e. SWATH-MS) to identify and quantify MHC-associated peptides. We also highlight selected biological applications and discuss important current technical limitations that need to be solved to accelerate the development of this field.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26628741      PMCID: PMC4762616          DOI: 10.1074/mcp.O115.052431

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  156 in total

1.  Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members.

Authors:  Kevin T Hogan; Jennifer N Sutton; Kyo U Chu; Jennifer A C Busby; Jeffrey Shabanowitz; Donald F Hunt; Craig L Slingluff
Journal:  Cancer Immunol Immunother       Date:  2004-09-16       Impact factor: 6.968

2.  Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra.

Authors:  John D Venable; Meng-Qiu Dong; James Wohlschlegel; Andrew Dillin; John R Yates
Journal:  Nat Methods       Date:  2004-09-29       Impact factor: 28.547

3.  The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome.

Authors:  Etienne Caron; Renée Charbonneau; Gabrielle Huppé; Sylvie Brochu; Claude Perreault
Journal:  Int Immunol       Date:  2005-11-01       Impact factor: 4.823

Review 4.  Mechanisms of MHC class I-restricted antigen processing and cross-presentation.

Authors:  Peter Cresswell; Anne L Ackerman; Alessandra Giodini; David R Peaper; Pamela A Wearsch
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

Review 5.  Mass spectrometry and protein analysis.

Authors:  Bruno Domon; Ruedi Aebersold
Journal:  Science       Date:  2006-04-14       Impact factor: 47.728

Review 6.  Contribution of mass spectrometry-based proteomics to immunology.

Authors:  Nina Hillen; Stefan Stevanovic
Journal:  Expert Rev Proteomics       Date:  2006-12       Impact factor: 3.940

7.  The turnover kinetics of major histocompatibility complex peptides of human cancer cells.

Authors:  Elena Milner; Eilon Barnea; Ilan Beer; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2005-11-04       Impact factor: 5.911

8.  A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus.

Authors:  Magdalini Moutaftsi; Bjoern Peters; Valerie Pasquetto; David C Tscharke; John Sidney; Huynh-Hoa Bui; Howard Grey; Alessandro Sette
Journal:  Nat Biotechnol       Date:  2006-06-11       Impact factor: 54.908

9.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Authors:  Eric A Reits; James W Hodge; Carla A Herberts; Tom A Groothuis; Mala Chakraborty; Elizabeth K Wansley; Kevin Camphausen; Rosalie M Luiten; Arnold H de Ru; Joost Neijssen; Alexander Griekspoor; Elly Mesman; Frank A Verreck; Hergen Spits; Jeffrey Schlom; Peter van Veelen; Jacques J Neefjes
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

10.  A community resource benchmarking predictions of peptide binding to MHC-I molecules.

Authors:  Bjoern Peters; Huynh-Hoa Bui; Sune Frankild; Morten Nielson; Claus Lundegaard; Emrah Kostem; Derek Basch; Kasper Lamberth; Mikkel Harndahl; Ward Fleri; Stephen S Wilson; John Sidney; Ole Lund; Soren Buus; Alessandro Sette
Journal:  PLoS Comput Biol       Date:  2006-06-09       Impact factor: 4.475

View more
  82 in total

Review 1.  Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry.

Authors:  Lena Katharina Freudenmann; Ana Marcu; Stefan Stevanović
Journal:  Immunology       Date:  2018-05-08       Impact factor: 7.397

2.  Evaluating a Multiscale Mechanistic Model of the Immune System to Predict Human Immunogenicity for a Biotherapeutic in Phase 1.

Authors:  Lora Hamuro; Giridhar S Tirucherai; Sean M Crawford; Akbar Nayeem; Renuka C Pillutla; Binodh S DeSilva; Tarek A Leil; Craig J Thalhauser
Journal:  AAPS J       Date:  2019-07-24       Impact factor: 4.009

3.  Immunoproteasome deficiency in non-small cell lung cancer and its relevance to immunotherapy.

Authors:  Juergen Kast
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

4.  Origins of mass spectrometry-based proteomics.

Authors:  Matthias Mann
Journal:  Nat Rev Mol Cell Biol       Date:  2016-10-05       Impact factor: 94.444

Review 5.  The role of proteomics in the age of immunotherapies.

Authors:  Sarah A Hayes; Stephen Clarke; Nick Pavlakis; Viive M Howell
Journal:  Mamm Genome       Date:  2018-07-25       Impact factor: 2.957

6.  The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.

Authors:  Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Nimman Satumtira; Martha L Dorris; Mylinh T Nguyen; Robert E Hammer; Tri M Tran; Robert A Colbert; Joel D Taurog; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2017-02-10       Impact factor: 5.911

7.  Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.

Authors:  Bracha Shraibman; Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Gleb Slobodin; Itzhak Rosner; Carlos López-Larrea; Norbert Hilf; Sabrina Kuttruff; Colette Song; Cedrik Britten; John Castle; Sebastian Kreiter; Katrin Frenzel; Marcos Tatagiba; Ghazaleh Tabatabai; Pierre-Yves Dietrich; Valérie Dutoit; Wolfgang Wick; Michael Platten; Frank Winkler; Andreas von Deimling; Judith Kroep; Juan Sahuquillo; Francisco Martinez-Ricarte; Jordi Rodon; Ulrik Lassen; Christian Ottensmeier; Sjoerd H van der Burg; Per Thor Straten; Hans Skovgaard Poulsen; Berta Ponsati; Hideho Okada; Hans-Georg Rammensee; Ugur Sahin; Harpreet Singh; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2019-06       Impact factor: 5.911

8.  Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.

Authors:  Bracha Shraibman; Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Gleb Slobodin; Itzhak Rosner; Carlos López-Larrea; Norbert Hilf; Sabrina Kuttruff; Colette Song; Cedrik Britten; John Castle; Sebastian Kreiter; Katrin Frenzel; Marcos Tatagiba; Ghazaleh Tabatabai; Pierre-Yves Dietrich; Valérie Dutoit; Wolfgang Wick; Michael Platten; Frank Winkler; Andreas von Deimling; Judith Kroep; Juan Sahuquillo; Francisco Martinez-Ricarte; Jordi Rodon; Ulrik Lassen; Christian Ottensmeier; Sjoerd H van der Burg; Per Thor Straten; Hans Skovgaard Poulsen; Berta Ponsati; Hideho Okada; Hans-Georg Rammensee; Ugur Sahin; Harpreet Singh; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2018-08-02       Impact factor: 5.911

Review 9.  Current tools for predicting cancer-specific T cell immunity.

Authors:  David Gfeller; Michal Bassani-Sternberg; Julien Schmidt; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

10.  Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples.

Authors:  Tina Heyder; Maxie Kohler; Nataliya K Tarasova; Sabrina Haag; Dorothea Rutishauser; Natalia V Rivera; Charlotta Sandin; Sohel Mia; Vivianne Malmström; Åsa M Wheelock; Jan Wahlström; Rikard Holmdahl; Anders Eklund; Roman A Zubarev; Johan Grunewald; A Jimmy Ytterberg
Journal:  Mol Cell Proteomics       Date:  2016-07-24       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.